Download Full Report » PDF - Promega

Download Full Report » PDF - Promega

Corporate mind

Future Investments

Promega continues to invest in research and development

to strengthen the new product pipeline and expand technical

capabilities, increasing the ability to meet customer

needs and generate long-term growth. In 2012, investment

in research increased 8% over the prior year. These

investments in research and development

resulted in 31 new products in 2012

including a novel luciferase, NanoLuc®

luciferase, which The Scientist named as

a 2012 Top 10 Innovation. New products

are driving strong growth in our cellular analysis, genetic

identity and integrated solutions product lines.

In 2012, Promega also made significant investments in

infrastructure and additional capabilities. Implementation

of SAP continues globally with key distribution branches in

the UK and Germany online and initiation of all European

sales branches in process. With global implementation,

Promega will have a fully integrated efficient system to

allow continued growth.

Construction continues on a state-of-the-art cGMP facility

on the Madison campus that will provide the ability to

manufacture high-quality IVD products. This building is

scheduled to be completed in the fall of 2013. In November,

Promega celebrated the opening of a new facility for

its China operations. It will provide additional research,

development and cGMP manufacturing capabilities for

molecular diagnostics products for the Chinese market.

These are just a few of the investments that keep Promega

poised for sustainable success far into the future.

“This recent investment in the new

Shanghai cGMP manufacturing facility

represents Promega’s continued

commitment to life science in China.”

Promega CEO Bill Linton

Corporate Governance

Promega is governed by a Board of Directors, the Corporate

Leadership Team and global Branch Managers.

As the guiding force of the company, these groups are

responsible for setting company strategy and providing

organizational oversight. This group in total comprises 32

individuals; 28% of which are women.

Corporate mind Product reach Planet aware People care Community touch

Promega Corporate Responsibility Report 2012


More magazines by this user
Similar magazines